Frazier Life Sciences
Frazier Life Sciences is an investment firm that partners with and builds companies developing novel therapeutics, supporting them from early stages through public markets. It invests in private and public biopharmaceutical companies to advance innovative treatments across major therapeutic areas. Its mission is to support the development and commercialization of transformational therapeutics.
Facts
- Sectors
- Venture Capital and Private Equity Principals
- Employees
- 11–50
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Frazier Life Sciences
Weekly Tech Pulse: CRV closes $750M flagship fund as Frazier Life Sciences raises $1.3B; 4AG Robotics $40M, Strand Therapeutics $153M
This roundup reports venture funding moves: CRV closed a smaller $750M flagship fund after returning capital and shifting to a leaner strategy; Frazier Life Sciences raised a record $1.3B for biotech investments; other startups including 4AG Robotics and Strand Therapeutics secured $40M and $153M respectively.
Generative AI Poised to Boost Healthcare Efficiency but Slow Adoption and Sales Cycles Challenge Startups, Says Frazier’s Nader Naini
Generative AI and automation offer efficiency opportunities in the $4.5 trillion healthcare sector, but startups face challenges due to slow technology adoption and lengthy sales cycles. Venture funding in digital health exceeded $10 billion last year, with strong activity in Seattle-area startups and increased M&A.
People
-
Gordon Empey Executive, Partner, COO and General Counsel
-
Jennifer Martin Executive, Chief Financial Officer and Partner
Online
Questions about Frazier Life Sciences
What is Frazier Life Sciences?
frazierls.com
Who are the people behind Frazier Life Sciences?
Seattle Flow lists Gordon Empey (Executive, Partner, COO and General Counsel) and Jennifer Martin (Executive, Chief Financial Officer and Partner) at Frazier Life Sciences.
How many people work at Frazier Life Sciences?
Frazier Life Sciences has 11–50 employees.